Actionable genomic information for accurate diagnosis for metastatic patients with diagnostic ambiguity.

An accurate tumor type diagnosis is the first step in precision oncology.


Distinguishes between 50 tumor types

Identifies tumor types not previously considered

Most widely adopted gene expression test for diagnosis of unknown or uncertain tumors

Requires small tumor sample (~300 cells)

Treatment recommendations changed in 47% of patients based on incorporation of test results (more)^

Test results available within 5 business days
      (from receipt of specimen and required information)

Most validated gene expression test

100% covered by Medicare

Helping 7,500 physicians and 32,000 metastatic patients for over 8 years



^ NeoTYPE Cancer Profiles are performed and billed separately by our contracted reference laboratory, NeoGenomics Laboratories, Inc.


Laboratory photo Couple photo Photo of physician listening to patient